These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


166 related items for PubMed ID: 17516158

  • 21. Differential anti-atherosclerotic effects in the innominate artery and aortic sinus by the liver X receptor agonist T0901317.
    Peng D, Hiipakka RA, Reardon CA, Getz GS, Liao S.
    Atherosclerosis; 2009 Mar; 203(1):59-66. PubMed ID: 18639878
    [Abstract] [Full Text] [Related]

  • 22. Activation of liver X receptor induces macrophage interleukin-5 expression.
    Chen Y, Duan Y, Kang Y, Yang X, Jiang M, Zhang L, Li G, Yin Z, Hu W, Dong P, Li X, Hajjar DP, Han J.
    J Biol Chem; 2012 Dec 21; 287(52):43340-50. PubMed ID: 23150660
    [Abstract] [Full Text] [Related]

  • 23. LXR agonism improves TNF-α-induced endothelial dysfunction in the absence of its cholesterol-modulating effects.
    Spillmann F, Van Linthout S, Miteva K, Lorenz M, Stangl V, Schultheiss HP, Tschöpe C.
    Atherosclerosis; 2014 Jan 21; 232(1):1-9. PubMed ID: 24401210
    [Abstract] [Full Text] [Related]

  • 24. Effect of Quercetin on Atherosclerosis Based on Expressions of ABCA1, LXR-α and PCSK9 in ApoE-/- Mice.
    Li SS, Cao H, Shen DZ, Chen C, Xing SL, Dou FF, Jia QL.
    Chin J Integr Med; 2020 Feb 21; 26(2):114-121. PubMed ID: 31144159
    [Abstract] [Full Text] [Related]

  • 25. Global analysis of nuclear receptor expression and dysregulation in human osteoarthritic articular cartilage: reduced LXR signaling contributes to catabolic metabolism typical of osteoarthritis.
    Collins-Racie LA, Yang Z, Arai M, Li N, Majumdar MK, Nagpal S, Mounts WM, Dorner AJ, Morris E, LaVallie ER.
    Osteoarthritis Cartilage; 2009 Jul 21; 17(7):832-42. PubMed ID: 19217805
    [Abstract] [Full Text] [Related]

  • 26. Pharmacological activation of LXR in utero directly influences ABC transporter expression and function in mice but does not affect adult cholesterol metabolism.
    van Straten EM, Huijkman NC, Baller JF, Kuipers F, Plösch T.
    Am J Physiol Endocrinol Metab; 2008 Dec 21; 295(6):E1341-8. PubMed ID: 18840761
    [Abstract] [Full Text] [Related]

  • 27. Fetal liver X receptor activation acutely induces lipogenesis but does not affect plasma lipid response to a high-fat diet in adult mice.
    van Straten EM, van Meer H, Huijkman NC, van Dijk TH, Baller JF, Verkade HJ, Kuipers F, Plösch T.
    Am J Physiol Endocrinol Metab; 2009 Nov 21; 297(5):E1171-8. PubMed ID: 19724022
    [Abstract] [Full Text] [Related]

  • 28. Liver X receptor activation attenuates plaque formation and improves vasomotor function of the aortic artery in atherosclerotic ApoE(-/-) mice.
    Chen J, Zhao L, Sun D, Narsinh K, Li C, Zhang Z, Qi S, Wei G, Li W, Guo W, Cao F.
    Inflamm Res; 2012 Dec 21; 61(12):1299-307. PubMed ID: 22833121
    [Abstract] [Full Text] [Related]

  • 29. Effects of high dietary fat and cholesterol on expression of PPAR alpha, LXR alpha, and their responsive genes in the liver of apoE and LDLR double deficient mice.
    Zou Y, Du H, Yin M, Zhang L, Mao L, Xiao N, Ren G, Zhang C, Pan J.
    Mol Cell Biochem; 2009 Mar 21; 323(1-2):195-205. PubMed ID: 19067122
    [Abstract] [Full Text] [Related]

  • 30. [Activation of liver X receptor regulates fatty acid synthase expression in diabetic liver].
    Wang B, Cheng LJ, Gao ZN, Zhang XY, Huo M, Zhang DJ, Wu J, Wei MF.
    Zhonghua Yi Xue Za Zhi; 2008 Mar 25; 88(12):848-52. PubMed ID: 18756992
    [Abstract] [Full Text] [Related]

  • 31. Thymoquinone reduces cardiac damage caused by hypercholesterolemia in apolipoprotein E-deficient mice.
    Xu J, Zhu L, Liu H, Li M, Liu Y, Yang F, Pei Z.
    Lipids Health Dis; 2018 Jul 26; 17(1):173. PubMed ID: 30049280
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia.
    Kratzer A, Buchebner M, Pfeifer T, Becker TM, Uray G, Miyazaki M, Miyazaki-Anzai S, Ebner B, Chandak PG, Kadam RS, Calayir E, Rathke N, Ahammer H, Radovic B, Trauner M, Hoefler G, Kompella UB, Fauler G, Levi M, Levak-Frank S, Kostner GM, Kratky D.
    J Lipid Res; 2009 Feb 26; 50(2):312-26. PubMed ID: 18812595
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Coenzyme Q10 protects against hyperlipidemia-induced cardiac damage in apolipoprotein E-deficient mice.
    Zhang X, Liu H, Hao Y, Xu L, Zhang T, Liu Y, Guo L, Zhu L, Pei Z.
    Lipids Health Dis; 2018 Dec 08; 17(1):279. PubMed ID: 30526612
    [Abstract] [Full Text] [Related]

  • 37. LXR activation reduces proinflammatory cytokine expression in human CD4-positive lymphocytes.
    Walcher D, Kümmel A, Kehrle B, Bach H, Grüb M, Durst R, Hombach V, Marx N.
    Arterioscler Thromb Vasc Biol; 2006 May 08; 26(5):1022-8. PubMed ID: 16484597
    [Abstract] [Full Text] [Related]

  • 38. Induction of intestinal ATP-binding cassette transporters by a phytosterol-derived liver X receptor agonist.
    Kaneko E, Matsuda M, Yamada Y, Tachibana Y, Shimomura I, Makishima M.
    J Biol Chem; 2003 Sep 19; 278(38):36091-8. PubMed ID: 12847102
    [Abstract] [Full Text] [Related]

  • 39. [Expressions of atherosclerosis-related genes in aorta in young apoE/LDLR double knockout mice].
    Dai XD, Yin M, Jing W, DU HQ, Ye HY, Shang YJ, Zhang L, Zou YY, Qu ZP, Pan J.
    Sheng Li Xue Bao; 2008 Feb 25; 60(1):43-50. PubMed ID: 18288357
    [Abstract] [Full Text] [Related]

  • 40. The LXR agonist T0901317 promotes the reverse cholesterol transport from macrophages by increasing plasma efflux potential.
    Zanotti I, Potì F, Pedrelli M, Favari E, Moleri E, Franceschini G, Calabresi L, Bernini F.
    J Lipid Res; 2008 May 25; 49(5):954-60. PubMed ID: 18252848
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.